Connect with us

Headlines

Pharma Company with Eyecare Focus Names CEO

He previously served as interim chief.

mm

Published

on

EMERYVILLE, CA — NovaBay Pharmaceuticals Inc., a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, announces the appointments of Justin Hall as president and CEO and Jason Raleigh as chief financial officer.

Hall has served as interim president and CEO, and Raleigh as interim CFO, since March 2019.

“Justin and Jason have proven their leadership abilities by successfully implementing the shift in our U.S. commercial strategy we announced in March and executing the recent launch of our U.S. direct-to-consumer sales of Avenova on Amazon.com,” said Paul E. Freiman, chairman of NovaBay.

“This is a very exciting time at NovaBay as we launch Avenova Direct, making our leading lid and lash spray directly accessible to consumers without a prescription and at affordable pricing,” Hall said. “My close working relationships with our Board, principal investors, and sales force are key to quickly adjusting our strategy to rapidly address opportunities in the marketplace. We are on the move and we have momentum.”

Advertisement

Raleigh said: “I’m honored to be selected as CFO and appreciate the Board’s trust in my abilities. I look forward to continuing to work with Justin and the NovaBay team toward the continued successful commercialization of Avenova.”

Hall has served with NovaBay for six years in a variety of roles, including as corporate counsel, and has been actively involved in a number of operating functions, including the sales organization and manufacturing. Raleigh has been with NovaBay for more than three years and has nearly 20 years of financial experience.

Since launching in 2014, INVISION has won 23 international journalism awards for its publication and website. Contact INVISION's editors at editor@invisionmag.com.

Advertisement

SPONSORED VIDEO

SPONSORED BY Essilor USA

See What Happens When Patients Try Varilux® Lenses for the First Time

Take the first step toward truly satisfying your patients.

Promoted Headlines

Headlines

No Clear Image of This Eye Structure Existed ⁠— Until Now

Researchers at Indiana University took the first undistorted microscopic images of a part of the eye involved in glaucoma.

mm

Published

on

(Press Release) BLOOMINGTON, IN — Using methods originally developed by astronomers to view stars more clearly through Earth’s atmosphere, optometry researchers at Indiana University have taken the first undistorted microscopic images of a part of the eye involved in glaucoma.

The ability to clearly view this structure — known as the trabecular meshwork — could help improve treatment for glaucoma, according to a press release from the university. The work is reported in the journal of Translational Vision Science and Technology.

“Normally, clear fluid circulates inside the eye to supply nutrition and keep it ‘inflated’ to its normal shape,” said Dr. Brett King, chief of advanced ocular care services and associate clinical professor at the IU School of Optometry, who co-authored the study. “Alterations of the trabecular meshwork, which allows fluid to drain, elevates pressure in the eye, leading to glaucoma. The problem is the meshwork can only be seen poorly with the normal instruments in your doctor’s office, due to its location where the iris inserts into the wall of the eye, as well as the near-total reflection that occurs when looking through the cornea.”

The result of this low visibility is a lack of understanding about why age appears to cause the trabecular meshwork to function poorly. It also makes it difficult to study why certain glaucoma treatments that target the trabecular meshwork — such as laser therapies or invasive surgical procedures — fail while others succeed.

More effective treatments for glaucoma are needed since the number of people with the condition worldwide is expected to rise from 76 million in 2020 to over 111 million in 2040, disproportionally affecting people in Asia and Africa. In the U.S., it’s estimated that over 3 million people currently have glaucoma, costing the economy over $1.5 billion annually.

To view the trabecular meshwork, IU researchers modified an existing ophthalmic laser microscope with a programmable mirror able to deform in real time to correct for the eye’s imperfections. The technology, called “adaptive optics,” is accurate within ten-millionths of a millimeter, which is precise enough to visualize single cells or measure blood flow inside the retina.

Designed by astronomers to correct for the same atmospheric distortions that make stars appear to twinkle, adaptive optics uses a real or artificial point of light — whether an illuminated spot on the retina or a “guide star” in astronomy — to rapidly compute distortion rate and then correct for it.

According to study co-author Stephen Burns, the technology is similar to “a very expensive and very versatile funhouse mirror.” An IU faculty member who was not involved in this study, Donald Miller, was among the first imaging scientists to adapt the technology to imaging the eye’s retina in the late 1990s. Burns has been working on the subject since the early 2000s.

The new study extends the method to a part of the eye beyond the retina. In the paper, IU researchers report that the use of adaptive optics successfully imaged the trabecular meshwork in nine study participants, including two with pigment dispersion syndrome, an eye disorder that can lead to a form of glaucoma.

“Thanks to this research, the ocular drainage area of the eye can now be seen with much-improved clarity, which will improve our understanding of how this essential drainage area is being altered or damaged with age,” King said. “We’re very hopeful that this technology may help improve understanding and management of glaucoma, since many members of our team are clinicians who’ve managed patients with this disease for years.”

Additional authors on the study are Dr. Thomas J. Gast, a senior scientist at the IU School of Optometry, and Ting Luo and Dr. Kaitlyn A. Sapoznik, both Ph.D. students in vision science. The work was funded in part by the National Institutes of Health’s National Eye Institute and an Allergan Foundation Research Grant from the American Academy of Optometry.

Credit: Indiana University

Continue Reading

Headlines

Dark Chocolate May Not Help Eyesight After All, Study Finds

The new findings conflict with earlier research.

mm

Published

on

A new study conflicts with earlier research that suggested that flavanol-rich dark chocolate helps with vision.

In the new study, German researchers selected 22 healthy participants to consume either 20 grams of dark chocolate (400 milligrams of flavanols) or 7.5 grams of milk chocolate, the American Optometric Association reports.

They evaluated the participants’ visual function and retinal perfusion two hours later.

The researchers found “no differences in the effect of dark vs. milk chocolate on subjective visual acuity or contrast sensitivity, no change in retinal vessel density and no difference in arterial pressure as measured by OCT angiography,” according to AOA.

The findings counter those of a 2018 study that showed a small improvement in visual function following consumption of 72% cacao dark chocolate. (That study did note that the effect was probably of little clinical relevance.)

The new research consisted of a small double-blind, randomized clinical crossover trial. It was published online on Sept. 26 in JAMA Ophthalmology.

The researchers say additional trials with larger sample sizes may help rule out or in possible long-term benefits of dark chocolate.

Continue Reading

Headlines

Optical Retailer to Add 25 Stores, Expand Into 4 New States

It’s entering the Florida, Maryland, Pennsylvania and Wyoming markets.

mm

Published

on

DALLAS –Dallas-based optical retailer Eyemart Express announced that it plans to have 25 new locations operating by the end up 2019.

The company currently owns and operates 206 stores in 38 states, according to a press release. It’s expanding into four additional states: Florida, Maryland, Pennsylvania and Wyoming.

“The drive behind our aggressive growth strategy is to make prescription eyewear accessible and convenient for more communities,” said Michael Bender, Eyemart Express CEO. “Seeing clearly should not be a burden or an excessive expense for any family. We work hard to make all our locations an affordable one-stop shop for all eyewear needs.”

Eyemart Express carries more than 2,000 frames for prescription glasses and sunglasses, ranging from exclusive private label brands to well-known brands such as Converse, Longchamp, Calvin Klein, Ray-Ban and Nike. Stores also feature onsite labs so 90 percent of glasses can be ordered and received on the same day.

“Eyemart Express’ growth helps entire communities as well. Job creation is an important factor in determining new store locations — we examine where Eyemart Express can make the biggest contribution to local economies with career opportunities,” said Bender.

More than 300 jobs will be created for hourly wage earners as a result of the optical retailer’s expansion.

Continue Reading

Advertisement

Advertisement

Subscribe


BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Most Popular